Jan Schrooten
Co-founder & CEO | Antleron
Jan Schrooten is co-founder and CEO of Leuven-based Antleron, where he works on technologies and manufacturing strategies for advanced and regenerative therapies.
Trained as a materials engineer, he previously led biomaterials and tissue engineering research at KU Leuven and has spent much of his career trying to bridge the gap between scientific discovery and clinical application.
At the Health Tech Invest Morning, Jan will explore one of regenerative medicine’s hardest challenges: how do you turn a breakthrough in the lab into something that can actually be produced, scaled and delivered to patients?
A line-up of human-centric innovators
These extraordinary technology experts know their way around the latest innovations, but they always keep in mind that we're extra ordinary first.
